Cryoballoon-Assisted Pulmonary Vein Isolation and Left Atrial Roof Ablation Using a Simplified Sedation Strategy without Esophageal Temperature Monitoring: No Notable Thermal Esophageal Lesions and Low Arrhythmia Recurrence Rates after 2 Years.

EDEL LARA ablation atrial fibrillation cryoballoon esophageal lesion pulmonary vein isolation roof line

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
27 Jun 2024
Historique:
received: 02 06 2024
revised: 23 06 2024
accepted: 25 06 2024
medline: 13 7 2024
pubmed: 13 7 2024
entrez: 13 7 2024
Statut: epublish

Résumé

Atrial fibrillation (AF) ablation is increasingly effective for managing heart rhythm but poses risks like esophageal fistulas. Minimizing esophageal thermal lesions while simplifying procedures is crucial. This prospective study involved 100 consecutive AF patients undergoing cryoballoon ablation with simplified sedation, without esophageal temperature monitoring. Patients with paroxysmal AF (Group A) received pulmonary vein isolation only, while those with persistent AF (Group B) also had left atrial roof ablation. Gastroesophageal endoscopy was performed post-procedure to detect lesions, and cardiological follow-ups were conducted at 3, 12, and 24 months. The cohort included 69% men, with a median age of 65.5 years. Post-ablation endoscopy was performed in 92 patients; esophageal lesions were found in 1.1% of Group A and none of Group B. GERD was diagnosed in 14% of patients, evenly distributed between groups and not linked to lesion occurrence. Gastric hypomotility was observed in 16% of patients, with no significant difference between groups. At 24 months, arrhythmia-free survival was 88% in Group A and 74% in Group B. Cryoballoon-assisted pulmonary vein isolation, with or without additional left atrial roof ablation and without esophageal temperature monitoring during a simplified sedation strategy, shows low risk of esophageal thermal injury and effective ablation outcomes.

Sections du résumé

BACKGROUND BACKGROUND
Atrial fibrillation (AF) ablation is increasingly effective for managing heart rhythm but poses risks like esophageal fistulas. Minimizing esophageal thermal lesions while simplifying procedures is crucial.
METHODS METHODS
This prospective study involved 100 consecutive AF patients undergoing cryoballoon ablation with simplified sedation, without esophageal temperature monitoring. Patients with paroxysmal AF (Group A) received pulmonary vein isolation only, while those with persistent AF (Group B) also had left atrial roof ablation. Gastroesophageal endoscopy was performed post-procedure to detect lesions, and cardiological follow-ups were conducted at 3, 12, and 24 months.
RESULTS RESULTS
The cohort included 69% men, with a median age of 65.5 years. Post-ablation endoscopy was performed in 92 patients; esophageal lesions were found in 1.1% of Group A and none of Group B. GERD was diagnosed in 14% of patients, evenly distributed between groups and not linked to lesion occurrence. Gastric hypomotility was observed in 16% of patients, with no significant difference between groups. At 24 months, arrhythmia-free survival was 88% in Group A and 74% in Group B.
CONCLUSION CONCLUSIONS
Cryoballoon-assisted pulmonary vein isolation, with or without additional left atrial roof ablation and without esophageal temperature monitoring during a simplified sedation strategy, shows low risk of esophageal thermal injury and effective ablation outcomes.

Identifiants

pubmed: 39001260
pii: diagnostics14131370
doi: 10.3390/diagnostics14131370
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Damir Erkapic (D)

Department of Cardiology, Rhythmology and Angiology, Medical Clinic II, Diakonie Klinikum Jung Stilling, 57074 Siegen, Germany.
Department of Cardiology and Angiology, Medical Clinic I, University Hospital Giessen, 35392 Giessen, Germany.

Konstantinos Roussopoulos (K)

Department of Cardiology, Rhythmology and Angiology, Medical Clinic II, Diakonie Klinikum Jung Stilling, 57074 Siegen, Germany.

Marko Aleksic (M)

Department of Cardiology, Rhythmology and Angiology, Medical Clinic II, Diakonie Klinikum Jung Stilling, 57074 Siegen, Germany.

Korkut Sözener (K)

Department of Cardiology, Rhythmology and Angiology, Medical Clinic II, Diakonie Klinikum Jung Stilling, 57074 Siegen, Germany.

Karel Kostev (K)

Department of Epidemiology, Philipps-University Marburg, 35037 Marburg, Germany.

Josef Rosenbauer (J)

Department of Cardiology, Rhythmology and Angiology, Medical Clinic II, Diakonie Klinikum Jung Stilling, 57074 Siegen, Germany.

Samuel Sossalla (S)

Department of Cardiology and Angiology, Medical Clinic I, University Hospital Giessen, 35392 Giessen, Germany.

Dursun Gündüz (D)

Department of Cardiology, Rhythmology and Angiology, Medical Clinic II, Diakonie Klinikum Jung Stilling, 57074 Siegen, Germany.
Department of Cardiology and Angiology, Medical Clinic I, University Hospital Giessen, 35392 Giessen, Germany.

Joachim Labenz (J)

Department of Gastroenterology, Medical Clinic I, Diakonie Klinikum Jung Stilling, 57074 Siegen, Germany.

Christian Tanislav (C)

Department of Geriatrics and Neurology, Diakonie Klinikum Jung Stilling, 57074 Siegen, Germany.

Kay Felix Weipert (KF)

Department of Cardiology, Rhythmology and Angiology, Medical Clinic II, Diakonie Klinikum Jung Stilling, 57074 Siegen, Germany.
Department of Cardiology and Angiology, Medical Clinic I, University Hospital Giessen, 35392 Giessen, Germany.

Classifications MeSH